Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SI-BONE, Inc. Director's Dealing 2020

Aug 15, 2020

32647_dirs_2020-08-14_a4d72035-cb3d-4c05-a38a-68b41c3cf925.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2020-01-27

Reporting Person: Skyline Venture Partners V LP (N/A)
Reporting Person: Freund John Gordon (N/A)
Reporting Person: Skyline Venture Management V, LLC (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-27 Common Stock S 1000000.00 $21.50 Disposed 2819985.00 Indirect

Footnotes

F1: Shares are sold in the conjunction with SI-BONE, INC's public offering of common stock announced on January 21st, 2020.

F2: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, is a managing director of LLC and may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Although each of SVP V and LLC have ceased to be subject to the reporting requirements of Section 16 as a result of this sale of shares and the public offering, Dr. Freund is a director of SI-BONE, Inc. and, accordingly, remains subject to the reporting requirements of Section 16.